July 29, 2014 6:48 AM ET


Company Overview of Noven Pharmaceuticals, Inc.

Company Overview

Noven Pharmaceuticals, Inc. researches, develops, manufactures, markets, and sells prescription pharmaceutical products. Its products include Vivelle-Dot and Estradot, which are transdermal estrogen patches; CombiPatch and Estalis, which are combination estrogen/progestogen patches; Stavzor, a delayed release valproic acid softgel; Pexeva, a paroxetine mesylate; Lithobid, a lithium carbonate; Brisdelle, a paroxetine capsule for the treatment of vasomotor symptoms associated with menopause; and Daytrana, a methylphenidate transdermal system. It also manufactures Daytrana, a prescription central nervous system stimulant patch system for the treatment of ADHD in the age group of 6 to 17 years o...

11960 SW 144th Street

Miami, FL 33186

United States

Founded in 1987

610 Employees





Key Executives for Noven Pharmaceuticals, Inc.

Chief Executive Officer and President
Age: 48
Chief Financial Officer
Age: 56
Vice President of Operations
Chief Scientific Officer and Vice President
Age: 58
Chief Medical Officer and Executive Vice President of Product Development
Age: 59
Compensation as of Fiscal Year 2014.

Noven Pharmaceuticals, Inc. Key Developments

Noven Appoints Krista Roberts as Vice President of Operations

Noven Pharmaceuticals, Inc. announced the appointment of Krista Roberts as the company's new Vice President of Operations. In this role, Roberts will be responsible for all Noven manufacturing and related operations, reporting to Jeffrey Eisenberg, Noven's President and Chief Executive Officer. Roberts succeeds Richard Gilbert, who retired in April 2014. Roberts has over 15 years' experience in the pharmaceutical and medical device industries. Prior to joining Noven, she held various positions within Baxter International, serving most recently as Plant Manager of Baxter's 600+ person manufacturing facility in Cleveland, Mississippi. Her prior roles at Baxter included Director of Manufacturing, Manufacturing Manager, Manufacturing Superintendent, Department Engineer, and Manufacturing Supervisor.

Noven Pharmaceuticals, Inc. Presents at BIO International Convention, Jun-26-2014 11:30 AM

Noven Pharmaceuticals, Inc. Presents at BIO International Convention, Jun-26-2014 11:30 AM. Venue: San Diego Convention Center, San Diego, California, United States.

Noven Pharmaceuticals, Inc. Announces Settlement of Lidoderm(R) Patent Litigation with Endo Pharmaceuticals Inc., Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, Inc

Noven Pharmaceuticals, Inc. announced that it has entered into an agreement with Endo Pharmaceuticals Inc., Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, Inc. to settle all outstanding patent litigation related to Noven's lidocaine topical patch 5% product. An Abbreviated New Drug Application for Noven's product is currently pending at the U.S. Food and Drug Administration (FDA). If approved, Noven's product would be a generic version of Endo's Lidoderm(R). The agreement allows Noven to launch its generic Lidoderm(R) product on or after March 1, 2015, if the product is approved by the FDA. The agreement provides for an earlier launch under certain circumstances. Pursuant to the agreement, the litigation on this matter, currently pending in U.S. District Court for the District of Delaware, will be dismissed. Other terms of the settlement were not disclosed. The settlement agreement is subject to review by the U.S. Federal Trade Commission and the U.S. Department of Justice.

Similar Private Companies By Industry

Company Name Region
Emergent Product Development Gaithersburg, Inc. United States
7 Oaks Pharmaceutical Corp. United States
Tyler Distribution, Inc. United States
ILEX Pharmaceuticals, L.P United States
Pharmacia & Upjohn LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Noven Pharmaceuticals, Inc., please visit www.noven.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.